Research ExplorerScientific StaffPeter Buggisch Publications

Dr. ID: 3172347

Peter Buggisch

graph of relations
Affiliations
1 - 23 out of 23Page size: 50

Publications

  1. 2020

  2. Management of hepatic encephalopathy in Germany: a survey among physicians

    Labenz, C., Adarkwah, C. C., Wörns, M-A., Miehlke, S., Hofmann, W. P., Buggisch, P., Galle, P. R., Frieling, T. & Labenz, J., 01.2020, In: Z GASTROENTEROL. 58, 1, p. 49-56 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2018

  4. Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy. Still a concern in clinical practice?

    Christensen, S., Buggisch, P., Mauss, S., Böker, K. H. W., Schott, E., Klinker, H., Zimmermann, T., Weber, B., Reimer, J., Serfert, Y. & Wedemeyer, H., 05.2018, In: ADDICTION. 113, 5, p. 868-882 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2012

  6. Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.

    Petersen, J., Ratziu, V., Buti, M., Janssen, H. L. A., Brown, A., Lampertico, P., Schollmeyer, J., Zoulim, F., Wedemeyer, H., Sterneck, M., Berg, T., Sarrazin, C., Lütgehetmann, M. & Buggisch, P., 01.03.2012, In: J HEPATOL. 56, 3, p. 520-526 7 p., 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2011

  8. Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.

    Sarrazin, C., Schwendy, S., Möller, B., Dikopoulos, N., Buggisch, P., Encke, J., Teuber, G., Goeser, T., Thimme, R., Klinker, H., Boecher, W. O., Schulte-Frohlinde, E., Prinzing, R., Herrmann, E., Zeuzem, S. & Berg, T., 2011, In: GASTROENTEROLOGY. 141, 5, p. 1656-1664 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.

    Schulze Zur Wiesch, J., Pudelski, N., Hoepner, L., Supplieth, M., Buggisch, P., Lohse, A. W. & Lüth, S., 2011, In: HEPATOLOGY. 53, 4, p. 1405-1407 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection.

    Weich, V., Herrmann, E., Chung, T. L., Sarrazin, C., Hinrichsen, H., Buggisch, P., Gerlach, T., Klinker, H., Spengler, U., Bergk, A., Zeuzem, S. & Berg, T., 2011, In: J GASTROENTEROL. 46, 12, p. 1427-1436 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).

    Benten, D., Schulze Zur Wiesch, J., Sydow, K., Koops, A., Buggisch, P., Böger, R., Gaydos, C. A., Won, H., Franco, V., Lohse, A. W., Ray, S. C. & Balagopal, A., 2011, In: BMC GASTROENTEROL. 11, p. 107

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

    Heathcote, E. J., Marcellin, P., Buti, M., Gane, E., Man, D., Robert, A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., Manns, M., Kotzev, I., Buggisch, P., Buggisch, P., Weilert, F., Kurdas, O. O., Shiffman, M. L., Trinh, H., Gurel, S., Snow-Lampart, A., Borroto-Esoda, K., Mondou, E., Anderson, J., Sorbel, J. & Rousseau, F., 2011, In: GASTROENTEROLOGY. 140, 1, p. 132-143 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2010

  14. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

    van Bömmel, F., Man, D., Robert, A., Wedemeyer, H., Deterding, K., Buggisch, P., Buggisch, P., Erhardt, A., Hüppe, D., Stein, K., Trojan, J., Sarrazin, C., Böcher, W. O., Spengler, U., Wasmuth, H. E., Reinders, J. G. P., Möller, B., Peter, R., Feucht, H-H., Wiedenmann, B. & Berg, T., 2010, In: HEPATOLOGY. 51, 1, p. 73-80 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2009

  16. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.

    Berg, T., Weich, V., Teuber, G., Klinker, H., Möller, B., Rasenack, J., Hinrichsen, H., Gerlach, T., Spengler, U., Buggisch, P., Balk, H., Zankel, M., Neumann, K., Sarrazin, C. & Zeuzem, S., 2009, In: HEPATOLOGY. 50, 2, p. 369-377 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

    Poynard, T., Colombo, M., Bruix, J., Schiff, E., Terg, R., Flamm, S., Moreno-Otero, R., Carrilho, F., Schmidt, W., Berg, T., McGarrity, T., Heathcote, EJ., Gonçales, F., Diago, M., Craxi, A., Silva, M., Bedossa, P., Mukhopadhyay, P., Griffel, L., Burroughs, M., Brass, C., Alberti, A., Perez Alvarez, R., Anderson, F., Balart, L., Barange, K., Bodenheimer, H., Bourliere, M., Bronowicki, JP., Brunner, H., Buggisch, P., Buggisch, P., Calleja, JL., Carvalho, A., Caselmann, W., Causse, X., Cheng, W., Coelho, HS., Colombato, L., Crawford, D., Curciarello, J., Delwaide, J., Serra Desfilis, MA., Dusheiko, G., Enns, R., Esteban-Mur, R., Fainboim, H., Feinman, SV., Ferraz, ML., Ferreira Filho, RP., Focaccia, R., Gadano, A., George, J., Goncales, FL., Gordon, S., Gutfreund, KS., Haussinger, D., Hilzenrat, N., Hinrichsen, H., Horsmans, Y., Hultcrantz, R., Jacobson, I., Jeffrey, G., Kaita, K., King, P., Kwo, P., Lai, MY., Leggett, B., Lyra, L., Maieron, A., Manesis, EK., Manns, M., Marcellin, P., Marotta, P., Marsano, L., Mattos, A., Mauad, M., McCullough, AJ., McHutchison, J., Brandao Mello, C., Millison, L., Muellhaupt, B., Muzzillo, D. A., Ngu, M., Niederau, C., Pauly, MP., Peltekian, K., Perrillo, R., Picciotto, A., Pinchuk, L., Podda, M., Poo, JL., Poordad, F., Poupon, R., Ramos-Gomez, M., Reichen, J., Reindollar, R., Reymunde, A., Rizzetto, M., Roberts, S., Rosa, H., Rosenberg, W., Routley, D., Rumi, MG., Rustgi, V., Sanchez-Tapias, J., Shaikh, OS., Sherman, K., Sievert, W., Smith, C., Spengler, U., Sulkowski, M., Tanno, H., Teixeira, R., Toro, D., Torres, E., Castellanos Tortajada, G., Tran, A., Trepo, C., Tsai, N., Vale, AM., Varon, A., Planas Vila, R., Villa, E., Van Vlierberghe, H., Wong, F., Zachoval, R., Zeuzem, S., Zignego, AL. & Albrecht, J., 2009, In: GASTROENTEROLOGY. 136, 5, p. 1618-1628 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.

    Schulze Zur Wiesch, J., Pieper, D., Stahmer, I., Eiermann, T., Buggisch, P., Lohse, A. W., Hauber, J. & van Lunzen, J., 2009, In: CLIN INFECT DIS. 49, 3, p. 466-472 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

    Hézode, C., Forestier, N., Dusheiko, G., Ferenci, P., Pol, S., Goeser, T., Bronowicki, JP., Bourlière, M., Gharakhanian, S., Bengtsson, L., McNair, L., George, S., Kieffer, T., Kwong, A., Kauffman, RS., Alam, J., Pawlotsky, JM., Benhamou, Y., Couzigou, P., Grangé, JD., Marcellin, P., Mathurin, P., Serfaty, L., Tran, A., Trépo, C., Zarski, JP., Berg, T., Buggisch, P., Buggisch, P., Erhardt, A., Gerken, G., Günther, R., Rasenack, J., Schmidt, W., Spengler, U., Wedemeyer, H., Mutimer, D. & Zeuzem, S., 2009, In: NEW ENGL J MED. 360, 18, p. 1839-1850 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.

    Deterding, K., Wiegand, J., Grüner, N., Hahn, A., Jäckel, E., Jung, M. C., Buggisch, P., Galle, P., Berg, T., Hinrichsen, H., Potthoff, A., Zeuzem, S., Cornberg, M., Manns, M. & Wedemeyer, H., 2009, In: Z GASTROENTEROL. 47, 6, p. 531-540 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2008

  22. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

    Halangk, J., Sarrazin, C., Neumann, K., Puhl, G., Mueller, T., Teuber, G., Klinker, H., Hinrichsen, H., Buggisch, P., Landt, O., Weich, V., Bergk, A., Wiedenmann, B., Neuhaus, P., Berg, T. & Witt, H., 2008, In: J HEPATOL. 49, 3, p. 339-345 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.

    Rodríguez-Torres, M., Govindarajan, S., Solá, R., Clumeck, N., Lissen, E., Pessôa, M., Buggisch, P., Main, J., Depamphilis, J. & Dieterich, D. T., 2008, In: J HEPATOL. 48, 5, p. 756-764 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

    Hennes, E., Oo, Y. H., Schramm, C., Denzer, U. W., Buggisch, P., Wiegard, C., Kanzler, S., Schuchmann, M., Boecher, W., Galle, P. R., Adams, D. H. & Lohse, A. W., 2008, In: AM J GASTROENTEROL. 103, 12, p. 3063-3070 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.

    von Wagner, M., Hofmann, W. P., Teuber, G., Berg, T., Goeser, T., Spengler, U., Hinrichsen, H., Weidenbach, H., Gerken, G., Manns, M., Buggisch, P., Herrmann, E. & Zeuzem, S., 2008, In: HEPATOLOGY. 48, 5, p. 1404-1411 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Sorafenib in advanced hepatocellular carcinoma.

    Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J-F., Oliveira, D., Cosme, A., Santoro, A., Raoul, J-L., Forner, A., Schwartz, M., Porta, C., Zeuzem, S., Bolondi, L., Buggisch, P., Galle, P. R., Seitz, J-F., Borbath, I., Häussinger, D., Giannaris, T., Shan, M., Moscovici, M., Voliotis, D. & Bruix, J., 2008, In: NEW ENGL J MED. 359, 4, p. 378-390 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

    Marcellin, P., Heathcote, E. J., Buti, M., Gane, E., Man, D., Robert, A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., Manns, M., Kotzev, I., Buggisch, P., Buggisch, P., Weilert, F., Kurdas, O. O., Shiffman, M. L., Trinh, H., Washington, M. K., Sorbel, J., Anderson, J., Snow-Lampart, A., Mondou, E., Quinn, J. & Rousseau, F., 2008, In: NEW ENGL J MED. 359, 23, p. 2442-2455 23.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. 2007

  29. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.

    Kronenberger, B., Berg, T., Herrmann, E., Hinrichsen, H., Gerlach, T., Buggisch, P., Spengler, U., Goeser, T., Nasser, S., Wursthorn, K., Pape, G. R., Hopf, U. & Zeuzem, S., 2007, In: EUR J GASTROEN HEPAT. 19, 8, p. 639-646 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.

    Wiegand, J., Cornberg, M., Aslan, N., Schlaphoff, V., Sarrazin, C., Kubitschke, A., Buggisch, P., Ciner, A., Jaeckel, E., Manns, M. P. & Wedemeyer, H., 2007, In: ANTIVIR THER. 12, 3, p. 303-316 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.

    Steffen, M., Cornberg, M. & Buggisch, P., 2007, In: HEPATO-GASTROENTEROL. 54, 80, p. 2368-2372 80.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review